Capsule endoscopy (CE), introduced in 2000 and FDA-approved in 2001, remains a valuable tool for diagnosing gastrointestinal (GI) lesions, particularly in areas inaccessible to traditional endoscopy. While CE offers non-invasive imaging and improves detection of small bowel diseases and obscure GI bleeding, its widespread use is hindered by limitations such as lack of therapeutic capabilities, inability to obtain biopsies, reliance on peristalsis for movement, and time-consuming image interpretation.
Trending
- Top Insights from The Scope Forward Show 2025
- Augmented Reality to Improve Ergonomics; Positive Stool Tests and Polyp Location (GI & Endoscopy News)
- Capsule Endoscopy (GI & Endoscopy News)
- Underused Method of Colorectal Endoscopic Submucosal Dissection Could Improve Outcomes (Medscape)
- OpenAI launches ChatGPT Health, partners with b.well (MobiHealthNews)
- Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions (Freenome)
- Ro Launches Wegovy® Pill Through Integration with Novo Nordisk (Ro)
- The impact of the GI physician shortage (Becker’s GI & Endoscopy)
